{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "timestamp": "2019-03-26",
        "content": "Patient, female, 61 years old, underwent right middle and lower lobe resection + systematic lymph node dissection + closed thoracic drainage due to a lung mass.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Lobectomy",
              "approach": "open",
              "date": null,
              "location": "Right middle lobe",
              "performed_by": null,
              "outcome": null
            },
            {
              "name": "Lobectomy",
              "approach": "open",
              "date": null,
              "location": "Right lower lobe",
              "performed_by": null,
              "outcome": null
            },
            {
              "name": "Lymph node dissection",
              "approach": "open",
              "date": null,
              "location": "Thorax",
              "performed_by": null,
              "outcome": null
            },
            {
              "name": "Thoracic drainage",
              "approach": "closed",
              "date": null,
              "location": "Thorax",
              "performed_by": null,
              "outcome": null
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "Lung mass",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      },
      "custom_id": "graph_002_N0"
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "timestamp": "2019-03-26",
        "content": "Intraoperative findings: tumor located at the opening of the right lower lobe bronchus, approximately 4 cm \u00d7 3 cm in size.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Neoplasm",
              "body_part": "Bronchus",
              "modality": "Intraoperative findings",
              "finding": "tumor located at the opening of the right lower lobe bronchus, approximately 4 cm \u00d7 3 cm in size"
            }
          ]
        }
      },
      "custom_id": "graph_002_N1"
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "timestamp": "2019-03-26",
        "content": "Postoperative pathology: poorly differentiated LCNEC with metastasis to groups 3, 7, and 11 lymph nodes.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C80.1",
              "label": "Poorly differentiated neuroendocrine carcinoma",
              "status": "active"
            },
            {
              "code": "C77.9",
              "label": "Metastasis to lymph nodes",
              "status": "active"
            }
          ]
        }
      },
      "custom_id": "graph_002_N2"
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Tumor stage: T2aN2M0, stage IIIA. Immunohistochemistry (IHC): TTF-1 (+), Napsin A (-), Vimentin (-), CKp (+), CK5/6 (-), CK7 (+), P40 (-), Syn (+), CgA (+), CD56 (+), Ki-67 (proliferation index: 60%), ALK (+). NGS: EML4-ALK fusion mutation present.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "Malignant neoplasm of bronchus and lung",
              "status": "active"
            }
          ],
          "imaging": [
            {
              "type": "TNM staging",
              "body_part": "lung",
              "modality": "other",
              "finding": "T2aN2M0, stage IIIA"
            }
          ],
          "labs": [
            {
              "test": "TTF-1",
              "value": "positive",
              "unit": null,
              "flag": null
            },
            {
              "test": "Napsin A",
              "value": "negative",
              "unit": null,
              "flag": null
            },
            {
              "test": "Vimentin",
              "value": "negative",
              "unit": null,
              "flag": null
            },
            {
              "test": "CKp",
              "value": "positive",
              "unit": null,
              "flag": null
            },
            {
              "test": "CK5/6",
              "value": "negative",
              "unit": null,
              "flag": null
            },
            {
              "test": "CK7",
              "value": "positive",
              "unit": null,
              "flag": null
            },
            {
              "test": "P40",
              "value": "negative",
              "unit": null,
              "flag": null
            },
            {
              "test": "Synaptophysin",
              "value": "positive",
              "unit": null,
              "flag": null
            },
            {
              "test": "Chromogranin A",
              "value": "positive",
              "unit": null,
              "flag": null
            },
            {
              "test": "CD56",
              "value": "positive",
              "unit": null,
              "flag": null
            },
            {
              "test": "Ki-67",
              "value": "60",
              "unit": "%",
              "flag": null
            },
            {
              "test": "ALK",
              "value": "positive",
              "unit": null,
              "flag": null
            },
            {
              "test": "EML4-ALK fusion mutation",
              "value": "present",
              "unit": null,
              "flag": null
            }
          ]
        }
      },
      "custom_id": "graph_002_N3"
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Postoperative treatment: paclitaxel + lobaplatin chemotherapy combined with crizotinib 250 mg bid.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0030393",
              "dosage": "250 mg",
              "frequency": "bid",
              "modality": "oral",
              "indication": "Neoplasm",
              "start_date": null,
              "end_date": null
            },
            {
              "drug": "C0030393",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "indication": "Neoplasm",
              "start_date": null,
              "end_date": null
            },
            {
              "drug": "C0009375",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "indication": "Neoplasm",
              "start_date": null,
              "end_date": null
            }
          ]
        }
      },
      "custom_id": "graph_002_N4"
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Patient experienced severe gastrointestinal adverse reactions after 1 cycle of chemotherapy and stopped chemotherapy, continuing with oral crizotinib targeted therapy. Crizotinib was discontinued in 2022-04 due to severe drug-induced skin rash. During medication, the lesions were stable, with no postoperative tumor recurrence or interstitial pneumonia.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0975717",
              "dosage": null,
              "frequency": null,
              "modality": "oral",
              "start_date": null,
              "end_date": "2022-04",
              "indication": null
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "postoperative tumor recurrence",
              "status": "historical",
              "onset_date": null
            },
            {
              "code": null,
              "label": "interstitial pneumonia",
              "status": "historical",
              "onset_date": null
            }
          ],
          "allergies": [
            {
              "substance": null,
              "reaction": "drug-induced skin rash",
              "severity": "severe",
              "date_recorded": null
            }
          ]
        }
      },
      "custom_id": "graph_002_N5"
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "timestamp": "2023-08",
        "content": "PET/CT at another hospital showed slight narrowing of the left main bronchus.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Positron emission tomography",
              "body_part": "Left main bronchus",
              "modality": "PET/CT",
              "finding": "slight narrowing"
            }
          ]
        }
      },
      "custom_id": "graph_002_N6"
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient underwent right middle and lower lobe resection + systematic lymph node dissection + closed thoracic drainage due to a lung mass. Transition to intraoperative findings.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0023853"
          ],
          "change_type": "other",
          "target_domain": "imaging",
          "timestamp": "2019-03-26T00:00:00Z"
        }
      },
      "custom_id": "graph_002_N1_N2"
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Intraoperative findings of a 4cm x 3cm tumor at the opening of the right lower lobe bronchus. Transition to postoperative pathology.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0023853"
          ],
          "change_type": "other",
          "target_domain": "diagnosis",
          "timestamp": "2019-03-26T00:00:00Z"
        }
      },
      "custom_id": "graph_002_N2_N3"
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Postoperative pathology revealed poorly differentiated LCNEC with metastasis to groups 3, 7, and 11 lymph nodes. Transition to tumor staging and immunohistochemistry results.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "C0027051",
            "C0027048"
          ],
          "change_type": "other",
          "target_domain": "diagnosis"
        }
      },
      "custom_id": "graph_002_N3_N4"
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Tumor stage T2aN2M0, stage IIIA with IHC results: TTF-1 (+), Napsin A (-), Vimentin (-), CKp (+), CK5/6 (-), CK7 (+), P40 (-), Syn (+), CgA (+), CD56 (+), Ki-67 (60%), ALK (+). NGS: EML4-ALK fusion mutation present. Transition to postoperative treatment.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "C0027051",
            "C0027048"
          ],
          "change_type": "other",
          "target_domain": "medication"
        }
      },
      "custom_id": "graph_002_N4_N5"
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Postoperative treatment with paclitaxel + lobaplatin chemotherapy combined with crizotinib 250 mg bid. Transition to adverse reactions and medication changes.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0030393",
            "C0009375"
          ],
          "change_type": "discontinuation",
          "target_domain": "medication"
        }
      },
      "custom_id": "graph_002_N5_N6"
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Patient experienced severe gastrointestinal adverse reactions after 1 cycle of chemotherapy and stopped chemotherapy, continuing with oral crizotinib targeted therapy. Crizotinib was discontinued in 2022-04 due to severe drug-induced skin rash. During medication, the lesions were stable, with no postoperative tumor recurrence or interstitial pneumonia. Transition to PET/CT findings.",
        "transition_event": {
          "trigger_type": "spontaneous",
          "trigger_entities": [],
          "change_type": "other",
          "target_domain": "imaging",
          "timestamp": "2023-08T00:00:"
        }
      },
      "custom_id": "graph_002_N6_N7"
    }
  ]
}